Related Experiment Videos
Constitutive achlorhydria in mucolipidosis type IV
R Schiffmann1, N K Dwyer, I A Lubensky
1Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. raffis@helix.nih.gov
Summary
Mucolipidosis type IV patients exhibit elevated gastrin levels and impaired stomach acid production due to abnormal parietal cells. This suggests a defect in cellular trafficking critical for stomach acid secretion.
Area of Science:
- Gastroenterology
- Genetics
- Cell Biology
Background:
- Mucolipidosis type IV (ML4) is a rare genetic disorder causing neurological and eye problems.
- Its underlying metabolic defect remains largely unknown.
- Previous studies noted iron deficiency in some ML4 patients.
Purpose of the Study:
- To investigate the metabolic abnormalities in ML4 patients.
- To explore potential gastrointestinal manifestations and their underlying mechanisms.
- To gain insight into the cellular defect in ML4.
Main Methods:
- Prospective evaluation of 15 ML4 patients (ages 2-23).
- Blood gastrin and vitamin B12 level measurements.
- Gastroscopy and immunohistochemical analysis of gastric parietal cells.
- Assessment of H+/K+-ATPase localization.
Main Results:
- Elevated blood gastrin levels were observed in all but one patient.
- Gastric mucosal atrophy was noted in an older patient.
- Parietal cells showed large lysosomal inclusions and signs of partial activation.
- H+/K+-ATPase partially localized to the apical membrane.
Conclusions:
- ML4 patients are constitutively achlorhydric (lack stomach acid).
- Parietal cells in ML4 patients are partially activated.
- The defective protein in ML4 may be involved in vacuolar trafficking for parietal cell activation.